Last Updated: June 26, 2026

Alvogen Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ALVOGEN

ALVOGEN has fifty-four approved drugs.

There are two tentative approvals on ALVOGEN drugs.

Drugs and US Patents for Alvogen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen DISULFIRAM disulfiram TABLET;ORAL 091681-001 Aug 8, 2013 AB RX No No ⤷  Start Trial ⤷  Start Trial
Alvogen HYDROCODONE BITARTRATE hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 208269-003 Mar 1, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial
Alvogen NEVIRAPINE nevirapine TABLET, EXTENDED RELEASE;ORAL 204621-002 Nov 9, 2015 DISCN No No ⤷  Start Trial ⤷  Start Trial
Alvogen LIDEX fluocinonide SOLUTION;TOPICAL 018849-001 Apr 6, 1984 DISCN Yes No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Alvogen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen TAMBOCOR flecainide acetate TABLET;ORAL 018830-003 Jun 3, 1988 3,900,481 ⤷  Start Trial
Alvogen TAMBOCOR flecainide acetate TABLET;ORAL 018830-003 Jun 3, 1988 4,005,209 ⤷  Start Trial
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-003 Aug 1, 1984 4,012,444 ⤷  Start Trial
Alvogen SPECTAZOLE econazole nitrate CREAM;TOPICAL 018751-001 Dec 23, 1982 3,839,574 ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.